A phase 2 trial of lenvatinib 18 mg versus 14 mg once daily (QD) in combination with everolimus (5 mg QD) in renal cell carcinoma (RCC) after 1 prior VEGF-targeted treatment.Hilary Glen, Sumanta K. Pal, Javier Puente et al.|Journal of Clinical Oncology|2018Cited by 4
Clinical treatment and medical evaluation of the aircrew with renal cell carcinoma-6 cases attachedJianye Li, Di Li, Zehou Wang et al.|Chinese Journal of Aerospace Medicine|2011Cited by 0